STADA: Purchase of a generics business in Switzerland successfully concluded
31/01/2012
STADA: Purchase of a generics business in Switzerland successfully concluded
Share:
Related Posts
STADA Sets Stage at Key Biosimilars Event
STADA‘s Dr Christine Berndt, outlined the opportunities and challenges for Europe‘s biosimilars sector during the opening speech to around 250 delegates at Medicines for Europe‘s Biosimilar Medicines (BIOS26) Conference h
Taking a step. Sending a message. For most of us, these actions happen automatically. For people living with Parkinson’s disease, they can require focus, control and effort.